FIRST STEPS: A Pilot Randomized Study Analyzing the Preliminary Efficacy of the Incredible Years for Autism Spectrum
Fátima Valencia-Agudo1,2, Laia Villalta-Macià3,4, Elena Urbiola-Merina1
1Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Purpose:
Having access to parenting interventions in the early years is key to improve developmental outcomes of children with neurodevelopmental problems. The Incredible Years® Parent Program has been adapted for families of children with autism or language delays (IY-ASLD®). The aim of this study is to analyze the preliminary efficacy of the intervention in the Spanish public mental health services.
Methods:
The FIRST STEPS study is a multicenter, pilot randomized controlled trial. Sixty-two families of children with autism spectrum disorder and preterm children with communication and/or socialization difficulties (aged 2-5 years) were recruited. Due to the COVID-19 pandemic, the intervention was performed online. A generalized estimating equations model was conducted.
Results:
No significant differences in parental stress ([Formula: see text] = 2.01, [Formula: see text]0.640), depressive symptoms ([Formula: see text] = - 1.42, [Formula: see text]0.437), child psychopathology ([Formula: see text] = 0.74, [Formula: see text]0.886) ), positive parenting [Formula: see text] = 2.25, [Formula: see text]0.076) or total expressed emotion ([Formula: see text] = - 0.10, [Formula: see text]0.605) were found between groups at T2. In terms of expressed emotion at T2, a significant interaction was observed between positive comments at T1 (a subscale of the expressed emotion tool) and study group ([Formula: see text] = 0.75, [Formula: see text]0.007).
Conclusion:
Future studies should analyze the efficacy of the program using a larger sample. Families showing higher levels of expressed emotion might need more support during the therapy groups to improve this variable.
Trial Registration:
The protocol for the study was registered in ClinicalTrials.gov (ID number: NCT04358484. Unique Protocol ID: PIC-220-19).
More Related Videos
06:15Using the Visual World Paradigm to Study Sentence Comprehension in Mandarin-Speaking Children with Autism
Published on: October 3, 2018
11:14A Novel Experimental and Analytical Approach to the Multimodal Neural Decoding of Intent During Social Interaction in Freely-behaving Human Infants
Published on: October 4, 2015
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Learning Disabilities
Dyslexia
Dyslexia is a...
